title: [Drugs news].
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
authors.forename: C
authors.initials: C
authors.lastname: Lengellé
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
authors.forename: T
authors.initials: T
authors.lastname: Bejan-Angoulvant
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
authors.forename: F
authors.initials: F
authors.lastname: Beau-Salinas
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France. Electronic address: jonville-bera@chu-tours.fr.
authors.forename: A P
authors.initials: AP
authors.lastname: Jonville-Béra
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D001011:Aorta / Q000187:drug effects*; D001014:Aortic Aneurysm / Q000517:prevention & control*; D001262:Atenolol / Q000627:therapeutic use*; D002972:Cleft Palate / Q000139:chemically induced*; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives*; D006391:Hemangioma / Q000151:congenital* / Q000453:epidemiology*; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D008382:Marfan Syndrome / Q000188:drug therapy*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012878:Skin Neoplasms / Q000151:congenital* / Q000453:epidemiology*
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D019440:Anti-Obesity Agents; D000927:Anticonvulsants; D005632:Fructose; D001262:Atenolol; D019808:Losartan